Cognoa is developing AI-based digital diagnostics and personalized therapies to make earlier diagnoses and effective treatments available to more children to improve outcomes and lower behavioral healthcare costs.

When more healthcare providers are empowered to identify and treat behavioral conditions and developmental delays sooner, more children have the opportunity to benefit from treatments at a younger age when there is the greatest potential for improved lifelong outcomes.

Developed and validated at leading institutions


Cognoa's scientific and clinical advisors are nationally renowned leaders

  • Dennis Wall, PhD

    Associate Professor of Pediatrics Stanford School of Medicine

  • Clara Lajonchere, PhD

    Deputy Director, Institute of Precision Health UCLA

  • Daniel L. Coury, MD

    Chief, Developmental & Behavioral Pediatrics Nationwide Children’s Hospital

  • Lee Sanders, MD, MPH

    Chief, Division of General Pediatrics Stanford University

  • Janesta Noland, MD

    Adjunct Clinical Assistant Professor Stanford Children’s Health

  • Alan Greene, MD

    Adjunct Clinical Professor, Pediatrics

  • John Constantino, MD

    Director of the Intellectual and Developmental Disabilities Research Center, Washington University School of Medicine, St. Louis

  • Christopher Nichols, PhD, ABPP, ABPdN

    Adjunct Professor, Arizona State University

  • Ricki Robinson, MD

    Clinical Professor of Pediatrics, Keck School Medicine of USC and Senior Attending Physician, Children’s Hospital of Los Angeles

  • Colleen Kraft, MD, MBA, FAAP

    Pediatrician, Mia Bella Pediatrics,
    Mission Viejo, CA

If you are a Health Care Provider and are interested in learning more about Cognoa, enter your contact information here.